Latest News about FLGT
Recent news which mentions FLGT
This Breakout Healthcare Growth Stock Is Too Cheap to Miss
January 26, 2022
Tickers
FLGT
From Motley Fool
Why Shares of Fulgent Genetics Nearly Doubled in 2021
January 09, 2022
Tickers
FLGT
From Motley Fool
3 COVID Stocks That Could Double in 2022
January 03, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 03, 2022
From Benzinga
2 Cheap Growth Stocks to Buy for 2022
January 01, 2022
From Motley Fool
My 2 Favorite Healthcare Stocks for 2022
December 29, 2021
From Motley Fool
Corona Doom 3.0: Omicron Surge. Profiting From The Boom In COVID-19 Testing Due To The Omicron Wave
December 22, 2021
From Benzinga
5 Value Stocks In The Healthcare Sector
December 20, 2021
From Benzinga
Is Fulgent Genetics a Good Healthcare Stock to Buy?
December 08, 2021
From Motley Fool
How Wide Is Fulgent Genetics' Moat?
December 03, 2021
From Motley Fool
3 Stocks That Could Make You Richer in December (and Beyond)
December 02, 2021
From Motley Fool
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
From Benzinga
Jim Cramer Weighs In On Carnival, Canadian Pacific Railway And More
December 02, 2021
From Benzinga
56 Biggest Movers From Friday
November 29, 2021
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 26, 2021
From Benzinga
3 Small-Cap COVID Stocks With Huge Upside
November 25, 2021
From Motley Fool
The Monster Business Lurking Behind Fulgent's COVID Results
November 24, 2021
From Motley Fool
A Look Into Healthcare Sector Value Stocks
November 22, 2021
From Benzinga
3 Healthcare Stocks That Are Too Cheap to Ignore
November 22, 2021
From Motley Fool
How Is Fulgent Genetics Staying Ahead of Its Competition?
November 20, 2021
Tickers
FLGT
From Motley Fool
What Investors Should Like About Fulgent Genetics' Q3 Results
November 19, 2021
Tickers
FLGT
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 10, 2021
From Benzinga
Fulgent Genetics Q3 Revenues More Than Double; Raises FY21 Outlook
November 10, 2021
Tickers
FLGT
From Benzinga
Tickers
FLGT
From Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
Got $1,500? These 2 COVID Stocks Are Firing On All Cylinders
November 03, 2021
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.